Clinical Study 1: 1714-Serenitas
The 1714-Serenitas® culture:
A unique B. longum probiotic strain of human origin, developed in partnership with scientists and clinicians from one of the world’s leading centres of research on the gut-brain axis.
Clinical Study 2: 1714-Serenitas
OBJECTIVE: To investigate whether the B. longum 1714-Serenitas® probiotic could affect stress-related behaviour, physiology and cognitive performance of healthy people.